LEADER 01093nam0 2200289 450 001 000025811 005 20090520094334.0 010 $a0-8194-0923-5 100 $a20090520d1992----km-y0itay50------ba 101 0 $aeng 102 $aUS 105 $aa-------001yy 200 1 $aOcean optics 11$e20-22 July 1992, San Diego, California$fGary D. Gilbert, chair/editor$gsponsored and published by SPIE-the International Society for Optical Engineering 210 $aBellingham$cSPIE-the International society for optical engineering$dc1992 215 $aIX, 549 p.$cill.$d28 cm 225 2 $aSPIE Proceedings series$v1750 410 0$12001$aSPIE Proceedings series 500 10$aOcean optics 11$942956 610 1 $aOceanografia 676 $a551.47$v21$9Geomorfologia e idrosfera. Oceanografia dinamica 702 1$aGilbert,$bGary D. 710 02$aSociety of photo-optical instrumentation engineers$013342 801 0$aIT$bUNIPARTHENOPE$c20090520$gRICA$2UNIMARC 912 $a000025811 951 $aDISAM 551-O/1$bO 68$cDISAM$d2009 996 $aOcean optics 11$942956 997 $aUNIPARTHENOPE LEADER 03137oam 2201045zu 450 001 9910876930903321 005 20210807002912.0 010 $a0-470-03543-9 010 $a0-470-03542-0 035 $a(CKB)1000000000377320 035 $a(SSID)ssj0000354874 035 $a(PQKBManifestationID)11259209 035 $a(PQKBTitleCode)TC0000354874 035 $a(PQKBWorkID)10316218 035 $a(PQKB)10495621 035 $a(EXLCZ)991000000000377320 100 $a20160829d2006 uy 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 00$aVascular-targeted therapies in oncology 210 31$a[Place of publication not identified]$cJohn Wiley & Sons$d2006 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-470-01294-3 606 $aBlood Vessels 606 $aNeovascularization, Pathologic 606 $aAngiogenesis Inhibitors 606 $aEndothelial Cells 606 $aNeoplasms 606 $aDrug Delivery Systems 606 $aCardiovascular System 606 $aMetaplasia 606 $aAntineoplastic Agents 606 $aDrug Therapy 606 $aDiseases 606 $aEpithelial Cells 606 $aGrowth Inhibitors 606 $aAngiogenesis Modulating Agents 606 $aTherapeutic Uses 606 $aPathologic Processes 606 $aCells 606 $aTherapeutics 606 $aGrowth Substances 606 $aAnatomy 606 $aPharmacologic Actions 606 $aPhysiological Effects of Drugs 606 $aPathological Conditions, Signs and Symptoms 606 $aAnalytical, Diagnostic and Therapeutic Techniques and Equipment 606 $aChemical Actions and Uses 606 $aChemicals and Drugs 606 $aOncology$2HILCC 606 $aMedicine$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 2$aBlood Vessels 615 2$aNeovascularization, Pathologic 615 2$aAngiogenesis Inhibitors 615 2$aEndothelial Cells 615 2$aNeoplasms 615 2$aDrug Delivery Systems 615 2$aCardiovascular System 615 2$aMetaplasia 615 2$aAntineoplastic Agents 615 2$aDrug Therapy 615 2$aDiseases 615 2$aEpithelial Cells 615 2$aGrowth Inhibitors 615 2$aAngiogenesis Modulating Agents 615 2$aTherapeutic Uses 615 2$aPathologic Processes 615 2$aCells 615 2$aTherapeutics 615 2$aGrowth Substances 615 2$aAnatomy 615 2$aPharmacologic Actions 615 2$aPhysiological Effects of Drugs 615 2$aPathological Conditions, Signs and Symptoms 615 2$aAnalytical, Diagnostic and Therapeutic Techniques and Equipment 615 2$aChemical Actions and Uses 615 2$aChemicals and Drugs 615 7$aOncology 615 7$aMedicine 615 7$aHealth & Biological Sciences 676 $a616.99/4061 702 $aSiemann$b Dietmar W 801 0$bPQKB 906 $aBOOK 912 $a9910876930903321 996 $aVascular-targeted therapies in oncology$94204378 997 $aUNINA